BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30269836)

  • 1. Identification of a Novel Titin Variant Underlying Myocardial Involvement in Neurofibromatosis Type 1.
    Kizawa M; Nakagama Y; Shindo T; Ogawa S; Inuzuka R
    Can J Cardiol; 2018 Oct; 34(10):1369.e5-1369.e7. PubMed ID: 30269836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction.
    Hastings R; de Villiers CP; Hooper C; Ormondroyd L; Pagnamenta A; Lise S; Salatino S; Knight SJ; Taylor JC; Thomson KL; Arnold L; Chatziefthimiou SD; Konarev PV; Wilmanns M; Ehler E; Ghisleni A; Gautel M; Blair E; Watkins H; Gehmlich K
    Circ Cardiovasc Genet; 2016 Oct; 9(5):426-435. PubMed ID: 27625337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy.
    Pourirahim M; Houshmand G; Abdolkarimi L; Maleki M; Kalayinia S
    BMC Cardiovasc Disord; 2024 Apr; 24(1):220. PubMed ID: 38654147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel heterozygous truncating titin variants affecting the A-band are associated with cardiomyopathy and myopathy/muscular dystrophy.
    Rich KA; Moscarello T; Siskind C; Brock G; Tan CA; Vatta M; Winder TL; Elsheikh B; Vicini L; Tucker B; Palettas M; Hershberger RE; Kissel JT; Morales A; Roggenbuck J
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1460. PubMed ID: 32815318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino Acid-Level Signal-to-Noise Analysis Aids in Pathogenicity Prediction of Incidentally Identified
    Connell PS; Berkman AM; Souder BM; Pirozzi EJ; Lovin JJ; Rosenfeld JA; Liu P; Tunuguntla H; Allen HD; Denfield SW; Kim JJ; Landstrom AP
    Circ Genom Precis Med; 2021 Feb; 14(1):e003131. PubMed ID: 33226272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titin in muscular dystrophy and cardiomyopathy: Urinary titin as a novel marker.
    Misaka T; Yoshihisa A; Takeishi Y
    Clin Chim Acta; 2019 Aug; 495():123-128. PubMed ID: 30959043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titin mutations and muscle disease.
    Kellermayer D; Smith JE; Granzier H
    Pflugers Arch; 2019 May; 471(5):673-682. PubMed ID: 30919088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titin mutation in familial restrictive cardiomyopathy.
    Peled Y; Gramlich M; Yoskovitz G; Feinberg MS; Afek A; Polak-Charcon S; Pras E; Sela BA; Konen E; Weissbrod O; Geiger D; Gordon PM; Thierfelder L; Freimark D; Gerull B; Arad M
    Int J Cardiol; 2014 Jan; 171(1):24-30. PubMed ID: 24315344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Titin Truncation Variant Linked to Familial Dilated Cardiomyopathy Found in a Japanese Family and Its Functional Analysis in Genome-Edited Model Cells.
    Hirayama-Yamada K; Inagaki N; Hayashi T; Kimura A
    Int Heart J; 2021 Mar; 62(2):359-366. PubMed ID: 33678800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac MRI as an Imaging Tool in Titin Variant-Related Dilated Cardiomyopathy.
    Banga S; Cardoso R; Castellani C; Srivastava S; Watkins J; Lima J
    Cardiovasc Revasc Med; 2023 Jul; 52():86-93. PubMed ID: 36934006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful heart transplant in a child with congenital core myopathy and delayed-onset restrictive cardiomyopathy due to recessive mutations in the titin (TTN) gene.
    Wacker J; Di Bernardo S; Lobrinus JA; Jungbluth H; Gautel M; Beghetti M; Fluss J
    Pediatr Transplant; 2023 Sep; 27(6):e14561. PubMed ID: 37345726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting Genetic Variants in Titin in Patients With Muscle Disorders.
    Savarese M; Maggi L; Vihola A; Jonson PH; Tasca G; Ruggiero L; Bello L; Magri F; Giugliano T; Torella A; Evilä A; Di Fruscio G; Vanakker O; Gibertini S; Vercelli L; Ruggieri A; Antozzi C; Luque H; Janssens S; Pasanisi MB; Fiorillo C; Raimondi M; Ergoli M; Politano L; Bruno C; Rubegni A; Pane M; Santorelli FM; Minetti C; Angelini C; De Bleecker J; Moggio M; Mongini T; Comi GP; Santoro L; Mercuri E; Pegoraro E; Mora M; Hackman P; Udd B; Nigro V
    JAMA Neurol; 2018 May; 75(5):557-565. PubMed ID: 29435569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
    Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
    J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titin-Truncating Variants Increase the Risk of Cardiovascular Death in Patients With Hypertrophic Cardiomyopathy.
    Zhang C; Zhang H; Wu G; Luo X; Zhang C; Zou Y; Wang H; Hui R; Wang J; Song L
    Can J Cardiol; 2017 Oct; 33(10):1292-1297. PubMed ID: 28822653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies.
    Jolfayi AG; Kohansal E; Ghasemi S; Naderi N; Hesami M; MozafaryBazargany M; Moghadam MH; Fazelifar AF; Maleki M; Kalayinia S
    Sci Rep; 2024 Mar; 14(1):5313. PubMed ID: 38438525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titin mutations: the fall of Goliath.
    Neiva-Sousa M; Almeida-Coelho J; Falcão-Pires I; Leite-Moreira AF
    Heart Fail Rev; 2015 Sep; 20(5):579-88. PubMed ID: 26024954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.
    Beqqali A; Bollen IA; Rasmussen TB; van den Hoogenhof MM; van Deutekom HW; Schafer S; Haas J; Meder B; Sørensen KE; van Oort RJ; Mogensen J; Hubner N; Creemers EE; van der Velden J; Pinto YM
    Cardiovasc Res; 2016 Oct; 112(1):452-63. PubMed ID: 27496873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyopathy and Preeclampsia.
    Gammill HS; Chettier R; Brewer A; Roberts JM; Shree R; Tsigas E; Ward K
    Circulation; 2018 Nov; 138(21):2359-2366. PubMed ID: 30021846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of TITIN Gene Truncating Variant Mutations and 5-Year Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
    Anderson JL; Christensen GB; Escobar H; Horne BD; Knight S; Jacobs V; Afshar K; Hebl VB; Muhlestein JB; Knowlton KU; Carlquist JF; Nadauld LD
    Am J Cardiol; 2020 Dec; 137():97-102. PubMed ID: 32998006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.